Key result
Non-HDL-C, remnant cholesterol, and Lp(a) emerge as non-fasting ASCVD risk markers in Indian women.
Answers are grounded in this paper and cite their sources.
Lipoprotein(a), remnant cholesterol, and non-HDL-C are highlighted as practical, non-fasting markers for predicting atherosclerotic cardiovascular disease risk, with a specific focus on Indian women.
Dyslipidemia is a known risk factor for cardiovascular (CV) diseases. Low-density lipoprotein cholesterol is considered the primary target in dyslipidemia management. Recently, interest has grown in the roles of lipoprotein(a), remnant cholesterol, and non-high-density lipoprotein cholesterol as alternative, reliable goals. These markers are advantageous as they are easily estimated, do not require fasting, and provide dependable parameters for predicting atherosclerotic CV disease risk. Evolving data on these parameters in Indian women may help assess CV risk in this population.
No takes yet. Share an insight, caveat, or question.
Oruganti et al. (2025) conducted a review in Dyslipidemia. Lipoprotein(a), remnant cholesterol, and non-HDL-C was evaluated. Lipoprotein(a), remnant cholesterol, and non-HDL-C are emerging as reliable, non-fasting alternative targets for assessing atherosclerotic cardiovascular disease risk in Indian women.
Synapse has enriched 10 related papers. Consider them for comparative context: